Welcome back to Health Unlocked: The Power of Salutogenesis. In today's episode, Jasen Petersen dives deep into the cutting-edge research and real-world results behind Ion Gel, a novel wound-healing therapy by The Ionic Alliance Foundation. Jasen shares the surprising journey from cosmetic innovation to clinical applications in treating severe wounds, chronic diseases, and even cancer. He'll explore what the data shows, why the results are both intriguing and hard to dismiss, and the challenging questions researchers and clinicians still need to answer. Jasen also walks us through the next steps for validating this treatment, including the hurdles of running clinical trials, securing funding, and building a research community. If you're interested in how innovative science can redefine healing and health care, this episode will unlock a new perspective.

Timestamps:

00:00 Unexpected uses and early challenges

04:33 Improving life with ion gel

07:19 Evaluating wound treatment outcomes

13:02 Cellular healing and cofactors explained

15:39 Exploring microimmune dynamics in healing

20:19 Preparing research for publication

24:13 Planning multi-location clinical trials

25:53 Promising study on microimmune dynamics

29:37 Future plans for product development

32:34 Discussing a reverse merger option

36:38 Advantages of Development Spin-Offs

41:03 Understanding Decentralized Science (DeSci)

42:05 Ensuring Ethical IP Governance

45:14 Wrapping up the episode

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Ionic Alliance Group - https://ionicalliance.com/

Ionic Alliance Foundation - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Podcast - https://powerofsalutogenesis.com/

Welcome back to Health Unlocked! In this episode, we dive deep into the world of salutogenesis with Jasen Petersen from the Ionic Alliance Foundation. With summer winding down and back-to-school season in full swing, Jasen shares a personal update on homeschooling and his ongoing work in innovative health technology, including his journey toward finalizing a patent.

Today’s conversation kicks off by demystifying the differences between cell-based therapies and the ionic cofactor matrix known as “IBAL.” Jasen breaks down how traditional therapies aim to force specific changes at the cellular level, while IBAL takes a radically different, supportive approach, focusing on enhancing the microimmune terrain and restoring essential cofactors so cells can operate at their best. We explore how this technology could impact wound healing, chronic versus acute conditions, and its role alongside cutting-edge treatments like stem cell therapy.

We also touch on the regulatory challenges of bringing such solutions to market, the importance of efficacy versus safety, and the future roadmap for IBAL-based products. Plus, Jasen announces exciting funding initiatives to accelerate this game-changing research.

Stay tuned as we unlock the science, strategy, and stories behind the next generation of regenerative health!

Timestamps:

00:00 Defining cell-based therapy terms

06:29 Discussing ionic cofactor matrix

09:35 Nutrient roles in wound healing

12:49 Supplying Necessary Cell Cofactors

14:02 Understanding mineral synergy in cells

18:28 Effects of cryogenic drugs

22:41 Cell self-termination and zinc's role

25:16 Chronic vs. Acute Conditions Explained

27:24 Cell-based therapies and regulation

32:41 Cellular healing and cofactors

35:27 Challenges of Stem Cell Therapy

38:32 Funding and partnerships discussion

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked. In this episode, Jasen Petersen dives into the patient side of access to innovative wound care solutions like the Ion Gel, spotlighting how patients, providers, and small businesses can get involved in a rapidly evolving healthcare landscape. After exploring the infrastructural and supply-side mechanics in previous episodes, today’s conversation shifts to practical questions: How is this work being funded? Where can patients actually access these products? And what are the challenges for clinics and practitioners seeking to introduce new treatments? Jasen discusses regulatory pathways, real-world studies happening in Mexico, the importance of affordability, and creative ways ordinary businesses can support healthcare innovation like re-routing credit card processing fees to charitable foundations. Whether you’re a patient hoping for better outcomes, a clinician exploring new protocols, or simply someone curious about the future of patient-driven innovation, this episode is packed with insights you won’t want to miss.

Timestamps:

00:00 Discussing foundation's early funding

04:47 Discussing IP and community involvement

06:44 Availability of Ion Gel ZCM-25

12:38 Outsourcing for Safety and Efficiency

15:09 Insurance impact on wound care pricing

18:18 Conducting effective placebo-controlled trials

22:19 Efficacy and cost of cosmetic products

26:03 Challenges in Tracking Treatment Success

26:51 IonGel effectiveness and wound healing

33:27 Challenges with cardiogenic drug training

34:53 How cell-based treatments work

38:51 Adjusting cell dosage and frequency

42:57 Future plans for product distribution

45:53 From anecdotal evidence to medical use

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked, where we dive deep into the real-world challenges and breakthroughs in health innovation. In today’s episode, we’re joined once again by Jasen Petersen, who tackles some of the unanswered questions from previous conversations, this time pulling back the curtain on what “terrain support” actually means for patients and practitioners. We explore how the regulatory landscape shapes which claims can be made about cutting-edge products like Ion Gel, and why certain benefits remain unsaid even when the evidence is compelling. Jasen takes us through the complex process of classifying medical devices, what it means for safety and accessibility, and the strategic thinking behind spinning off development companies to advance multiple health solutions without sacrificing focus or effectiveness. Plus, we get a glimpse into how the future of funding and innovation might look, where collaboration thrives and skepticism, even from the scientific community, drives progress. Stick around for a candid, thoughtful conversation on the intersections of science, regulation, and building something truly new in health care.

Timestamps:

00:00 Discovering wound healing insights

04:24 Class 1 medical device safety

09:21 Goal of developing Class 1 device

13:15 Promoting a new wound healing gel

15:19 Prioritizing safety and funding strategies

19:24 Observing wound healing process

22:47 Focusing on wound healing startups

27:03 Valuing different components of IP

28:41 Collaborative company operations strategy

31:39 Drug development and investor milestones

36:38 Nonprofit funding strategy teaser

40:52 Community event with parade and helicopter

42:52 Large turnout for 250th Fun Run

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

The conversation focused on recent developments surrounding a newly granted device patent, often referred to as the "IBAL patent." A key theme that emerged was how this patent, covering ionic cofactor matrices and essential ion delivery for local applications, is shaping the strategy of a nonprofit organization dedicated to advancing this technology across various medical and commercial fields. The discussion explored the innovative spin-out model being used to create specialized development companies for different indications such as wound healing, psoriasis, eczema, and skin cancer, each benefiting from shared intellectual property while maintaining independence.

Several points were raised, including the reasoning behind a nonprofit holding patents, the benefits and challenges of the collaborative licensing approach, and the significant impact of recent reimbursement changes in wound care markets. Listeners will also hear about opportunities for researchers, practitioners, patients, and capital partners to participate in the mission, as well as new fundraising mechanisms designed to support the ongoing expansion and accessibility of the technology.

Timestamps:

00:00 Protecting and promoting the technology

04:56 Patent Strategy for Medical Applications

08:08 Collaborative model for IP sharing

13:08 Finding the right people for niche markets

16:31 Collaborating on IP development

18:27 Early manufacturing possibilities

21:10 Ion gel benefits and cost savings

25:23 Pricing Strategy and Profitability

29:38 Support for practitioners and researchers

33:00 Promoting the podcast and fundraiser

37:19 Nonprofit collaboration for fee savings

39:15 Discussing funding challenges

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked, where we dive deep into the science and strategy of healing. In today’s episode, we continue our exploration of the power of salutogenesis with Jasen Petersen. Picking up right where we left off, the conversation clarifies critical nuances from the previous episode, especially around the skepticism faced when presenting unexpected wound healing data to the medical community.

Jasen shares firsthand experiences from clinical work in Mexico, where a novel ion gel, initially introduced as a generic antimicrobial, produced unprecedented results in chronic wound healing, surprising practitioners and raising questions about the product's efficacy and underlying mechanisms. Jasen breaks down why these outcomes appear “impossible” from a conventional medical perspective, discusses the difference between cratogenic and salutogenic interventions, and dissects the challenges of presenting unconventional data to skeptical experts.

He’ll also cover practical issues in research design, data collection, and the next steps for publication, business development, and bringing this promising therapy to a larger audience. If you’re curious about the future of wound care, cellular healing, or the scientific process itself, this is an episode you won’t want to miss.

Timestamps:

00:00 Initial skepticism in Mexico markets

03:21 Ion gel heals a severe wound

07:31 Wound healing phases and products

12:42 Discussing chronic wound healing study

14:45 Discussing wound healing trials

18:52 Discussing efficacy and visual results

22:03 Zinc and copper in scar healing

26:38 Discussing limitations of cellogenic medicine

29:32 Publishing the micro immune dynamics paper

30:49 Discussing study focus on various diseases

34:17 Dealing with patents and fundraising

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked! In this episode, we dive into groundbreaking developments in wound care with Jasen Petersen, who recently attended the Symposium of Advanced Wound Care Conference in Charlotte, North Carolina. Jasen shares his experience presenting compelling clinical data on a novel topical ionic cofactor gel for chronic wounds - data so impressive that it met skepticism from the clinical community. We discuss the challenges of clinical trial design, biases in wound care research, and the hurdles of bringing innovative therapies to market, especially as a nonprofit. Jasen also gives us a glimpse into upcoming research, regulatory roadblocks, and how unconventional paths like decentralized science and industry collaboration might unlock better care for patients with chronic wounds. Stay tuned as we explore the realities, hopes, and frustrations behind changing the status quo in healthcare innovation.

Timestamps:

00:00 Talking about the conference experience

05:54 Discussing survivor bias in data

08:23 Conducting a prospective study in Mexico

10:04 Wound healing innovation conference

15:45 Using pig ECM for wound healing

19:04 Discussion on clinical trial criteria

20:10 Limitations of retrospective studies

25:43 Deciding on data collection strategy

27:19 Facing funding study challenges

30:58 Navigating US device approval

34:56 Personal experiences with a remedy

38:12 Discussing the pricing of hydrogel

41:18 Discussing KM analysis for wound closure

45:12 Building the Ionic Alliance Foundation

47:22 Product efficacy and user feedback

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/

Welcome back to Health Unlocked: The Power of Salutogenesis, where we explore cutting-edge ideas shaping the future of healthcare. In this episode, Jasen Petersen discusses how Ion Biotechnology is pivoting its US market entry strategy amidst shifting crypto and DeSci (Decentralized Science) market conditions.

Instead of pursuing the costly and complex 510k regulatory pathway immediately, he reveals a new plan centered on launching the Ion Gel as a Class 1 medical device or even as a cosmetic product, leveraging the terrain support concept. This approach not only allows faster access to the US market and clinical data generation but also provides a foundation for stronger future regulatory submissions. Along the way, he covers the importance of academic publication, community involvement via token funding, and maintaining transparency as the project evolves.

Tune in to get a real-time look at how innovation, regulation, and community engagement intersect in biotech.

Timestamps:

00:00 Finding a cost-effective FDA strategy

06:17 FDA classification and product function

09:33 Understanding product claims and regulations

12:51 Preventing diabetic foot ulcers

17:15 Overview of the research papers

21:30 Launching token before DAO

24:50 Presenting research and generating interest

27:22 FDA reclassification and strategy

31:37 Using real-world data for strategy

35:26 Navigating FDA classification challenges

38:09 Connecting with Jason and updates

39:50 Wrapping up the episode

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/